The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Pivotal phase 3 data for pembrolizumab in high-risk early-stage triple-negative breast cancer (TNBC)
Results from the Phase 3 KEYNOTE-522 trial have been published in the New England Journal of…